Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1 [Phase 1]
An extension Phase 1 study update evaluating the long-term equivalence of CT-P13 with infliximab (Remicade) in patients with Ankylosing Spon…
-
CLINICAL_TRIALS research · 2013-07-17Clinical Trial Update: A Multicenter Registry of Adalimumab in Chinese Adult Patients With Active Ankylosing Spondylitis
A multicenter registry evaluating adalimumab in Chinese adults with active ankylosing spondylitis; trial status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: Effects of Cardiovascular Training in Individuals With Ankylosing Spondylitis [NA]
Completed clinical trial evaluating the effects of cardiovascular training in individuals with Ankylosing Spondylitis.
-
FDA approval · 2013-06-12FDA Approved: MELOXICAM — Supplemental Application (Carlsbad Technology, Inc.)
FDA approved a supplemental application for Meloxicam (Carlsbad Technology, Inc.), a generic NSAID, under ANDA077918. The approval concerns …
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker [Phase 4]
Phase 4 trial evaluating heart function in patients with rheumatoid arthritis and ankylosing spondylitis before and after TNF blocker therap…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Ustekinumab for the Treatment of Patients With Active Ankylosing Spondylitis [Phase 2]
The document reports the completion of a Phase 2 clinical trial evaluating ustekinumab for active ankylosing spondylitis.
-
FDA approval · 2013-05-15FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for Simponi (golimumab) from Janssen Biotech, Inc., expanding the labeling for the product.
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: 16.0040 Ankylosing Spondylitis Study [Phase 3]
A Phase 3 clinical trial for ankylosing spondylitis sponsored by Amgen has completed.
-
CLINICAL_TRIALS research · 2013-05-14Clinical Trial Update: Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).
AstraZeneca-sponsored completed trial assessed the prevalence of gastrointestinal risk factors in patients with osteoarthritis, rheumatoid a…
-
FDA approval · 2013-04-24FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
FDA approval · 2013-04-18FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approves a supplemental application for Aleve GelCaps to expand labeling for naproxen sodium, broadening indications for pain relief.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Functional Limitations Due To The Foot Involvement In Spondyloarthritis
A completed clinical trial evaluating how foot involvement affects functional limitations in patients with ankylosing spondylitis and psoria…
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS) [Phase 1]
Phase 1 trial PLANETAS evaluating the investigational autoimmune drug cT-p13 in Ankylosing Spondylitis has completed.
-
CLINICAL_TRIALS research · 2013-02-15Clinical Trial Update: An Observational, Retrospective, Multicenter, National Study for the Monitoring of Subjects Who Participated in the LoadET Clinical Trial
This document describes an observational, retrospective, multicenter national study to monitor subjects who participated in the LoadET clini…
-
CLINICAL_TRIALS guidance · 2013-02-13Clinical Trial Update: Referral Recommendations for Axial Spondyloarthritis
This is a completed clinical trial update that provides referral recommendations for axial spondyloarthritis. The conditions include ankylos…
-
CLINICAL_TRIALS research · 2013-02-13Clinical Trial Update: Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA)
A clinical trials update evaluating the ASAS classification criteria for identifying early axial spondyloarthritis, with sponsor Charite Uni…
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Efficacy and Safety of MEthylprednisolone Administered Intravenously for the Treatment of Patients With Active AnkyLosing spondyLitis (METALL) [Phase 2]
Phase 2 trial METALL evaluates intravenously administered methylprednisolone for active ankylosing spondylitis, focusing on efficacy and saf…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs [Phase 3]
Phase 3 trial evaluating tocilizumab (RoActemra/Actemra) in ankylosing spondylitis patients who failed NSAIDs was terminated, with results p…
-
FDA approval · 2013-02-07FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Aleve GelCaps (naproxen sodium) as a new dosage form for the Aleve product line, expanding th…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries
A completed clinical trial evaluating Humira (adalimumab) in active rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis in…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Post Marketing Surveillance of Remicade
The document reports the completion of a post-marketing surveillance study of Remicade (infliximab) in Korea assessing safety in Crohn's dis…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy [Phase 3]
This Phase 3 trial of tocilizumab in ankylosing spondylitis patients who failed TNF antagonist therapy was terminated. Results were posted i…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) [Phase 3]
Phase 3 trial of infliximab for axial spondyloarthritis has completed and results were posted in 2012.
-
FDA approval · 2012-12-10FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for ENBREL (etanercept) submitted by Immunex Corporation.
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Web-based Support to Manage Arthritis Pain [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating a web-based tool to help manage arthritis pain.